| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 14, 2026 | Dr. Maryam Zamani Honored as 2026 Medical Aesthetic Vanguard, Wins Three Additional Aesthetic Awards | Beverly Hills plastic surgeon recognized for leadership in aesthetic medicine and award-winning work in complex revision, reconstruction and body contouring
BEVERLY HILLS, Calif., Oct. 14, 2026 /PRNewswire-PRWeb/ -- Beverly Hills plastic su... |
| Sep 21, 2026 | Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) | Alkermes plc (Nasdaq: ALKS) today announced positive topline results from a phase 1 proof-of-concept study evaluating ALKS 7290, the company’s novel, investigational orexin 2 receptor (OX2R) agonist in development for the treatment of atten... |
| Sep 1, 2026 | Canada’s Drug Agency issues final positive recommendation supporting public reimbursement of Leqembi® | Canada’s Drug Agency issues final positive recommendation supporting public reimbursement of Leqembi®
Tue, Sep 01, 2026 07:00 CET Report this content
Stockholm, Sweden, September 1, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA ... |
| Aug 24, 2026 | Leqembi Iqlik® for initiation treatment launched in the US | Leqembi Iqlik® for initiation treatment launched in the US
Mon, Aug 24, 2026 14:05 CET Report this content
Stockholm, Sweden, August 24, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that lecanem... |
| Jul 29, 2026 | Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026 | Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
Wed, Jul 29, 2026 12:00 CET Report this content
Stockholm, Sweden, July 29, 2026 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the prel... |
| Jul 14, 2026 | More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026 | More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
Tue, Jul 14, 2026 17:15 CET Report this content
Stockholm, S... |
| Jul 13, 2026 | FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer’s disease | FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer’s disease
Mon, Jul 13, 2026 23:55 CET Report this content
Stockholm, Sweden, July 13, 2026 – BioArctic AB's (publ) (Nasdaq Stock... |
| Jul 12, 2026 | New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer’s disease | New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer’s disease
Sun, Jul 12, 2026 17:30 CET Report this content
Stockholm, Sweden, July 1... |
| Jun 30, 2026 | New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026 | New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
Tue, Jun 30, 2026 08:00 CET Report this content
Stockholm, Sweden, June 30, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai... |
| Jun 25, 2026 | PharmNovo reports broader therapeutic potential for PN6047 | PharmNovo reports broader therapeutic potential for PN6047
Thu, Jun 25, 2026 08:15 CET Report this content
PharmNovo AB announces today new preclinical findings supporting the potential of PN6047 in migraine and opioid withdrawal syndrome. ... |
| May 29, 2026 | Teal Health and WashU School of Medicine Partner to Launch Cervical Cancer Screening Pilot
Moving Outside the Clinic: Why Teal Health and WashU Medicine Are Distributing At-Home HPV Kits via Food Banks | What You Should Know
Virtual women’s health pioneer Teal Health has announced a strategic research collaboration with the Washington University School of Medicine in St. Louis to expand cervical cancer screening access.
Orchestrated through... |
| May 8, 2026 | Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S. | Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.
Fri, May 08, 2026 08:30 CET Report this content
Stockholm, Sweden, May 8, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the U.S. F... |
| Apr 29, 2026 | United Imaging Healthcare Releases 2025 ESG Report: Upgraded to MSCI "AA" Rating, Driving Sustainable Development Through Innovation | SHANGHAI, April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has released its 2025 Environmental, Social and Governance (ESG) Report, outlining the company's strategic framework, key initiatives, and long-term commit... |
| Dec 8, 2025 | Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model | Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs
SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer d... |
| Nov 25, 2025 | Eisai completes U.S. rolling sBLA submission for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose | Eisai completes U.S. rolling sBLA submission for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose
Tue, Nov 25, 2025 13:37 CET Report this content
Stockholm, Sweden, November 25, 2025 – BioArctic AB's (publ) (Nasdaq Stoc... |
| Oct 27, 2025 | Health Canada Grants Authorization for Leqembi® (lecanemab) | Health Canada Grants Authorization for Leqembi® (lecanemab)
Mon, Oct 27, 2025 00:35 CET Report this content
Stockholm, October 27, 2025 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has ... |
| Oct 14, 2025 | First patient treated with Leqembi® (lecanemab) in the Nordics | First patient treated with Leqembi® (lecanemab) in the Nordics
Tue, Oct 14, 2025 09:05 CET Report this content
Stockholm, October 14, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that Leqembi has now been made avail... |
| Oct 14, 2025 | Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025 | Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
Tue, Oct 14, 2025 07:00 CET Report this content
Stockholm, October 14, 2025 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced ... |
| Aug 13, 2025 | Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study | — Series B fundraise led by Deerfield Management enables scaling of pivotal clinical trial and commercial readiness activities for Reprieve® System
– First patient enrolled in FASTR II study by Washington University School of Medicine in St... |
| Jul 31, 2025 | Latest data presented at AAIC 2025 reinforces lecanemab’s clinical effect with consistent safety profile | Latest data presented at AAIC 2025 reinforces lecanemab’s clinical effect with consistent safety profile
Thu, Jul 31, 2025 01:30 CET Report this content
Stockholm, Sweden, July 31, 2025 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B... |
| Jul 30, 2025 | The Leukemia Research Foundation announces 2025-2027 research grant recipients | Thirteen new investigators from across the country have been awarded the Leukemia Research Foundation's 2025-2027 New Investigator Research Grant.
The Leukemia Research Foundation announces the recipients of the 2025-2027 New Investiga... |
| Jul 22, 2025 | Lecanemab four-year efficacy and safety data to be presented at AAIC 2025 | Lecanemab four-year efficacy and safety data to be presented at AAIC 2025
Tue, Jul 22, 2025 08:00 CET Report this content
Stockholm, Sweden, July 22, 2025 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present th... |
| Feb 24, 2025 | Health | Does lip balm help chapped lips? Here’s what to know | Does lip balm work?
For most, lip balm is a worthy ally in the fight against chapped lips. But some people can’t take fragrances, flavors and preservatives found in popular balms. When applied, they can sting instead of soothe.
“Those are t... |
| Feb 7, 2025 | Sales of Leqembi® totaled 13.3 billion yen in the fourth quarter 2024 | Sales of Leqembi® totaled 13.3 billion yen in the fourth quarter 2024
Fri, Feb 07, 2025 04:35 CET Report this content
Stockholm, Sweden, February 7, 2025 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today issued the... |
| Dec 21, 2024 | Vintage Philanthropy: Hollander Foundation Pours $25,000 into Prostate Cancer Research from Wine-Making Proceeds | The Hollander Foundation
Dr. Franklin Huang, a physician-scientist and medical oncologist who cares for patients with prostate cancer.
The Hollander Foundation, dedicated to supporting prostate cancer research, awarded its annual gift to Fr... |
| Nov 12, 2024 | Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders | Ground-breaking investigation leverages Metabolon's Global Discovery Panel for metabolite genome-wide association study (MGWAS) for cerebrospinal fluid (CSF) and brain metabolite levels as they pertain to neurodegenerative disorders
MO... |
| Oct 31, 2024 | Cardiology Profile: Memorial Cardiac and Vascular Institute's Joshua Saef, MD | Dr. Joshua Saef Memorial Healthcare System
Dr. Joshua Saef is an adult congenital cardiologist with Memorial Cardiac and Vascular Institute.
HOLLYWOOD, Fla., Oct. 31, 2024 /PRNewswire-PRWeb/ -- Dr. Joshua Saef is an adult congenital cardiol... |
| Sep 5, 2024 | Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding | From genetic causes of Parkinson's to the neurobiology of cognitive dysfunction, APDA-funded researchers begin new work.
NEW YORK, Sept. 5, 2024 /PRNewswire-PRWeb/ -- The American Parkinson Disease Association (APDA) has just awarded $... |
| Jul 27, 2024 | Lecanemab: A Beacon of Hope in Alzheimer’s Treatment | The Alzheimer’s Association International Conference (AAIC) 2024 is set to unveil groundbreaking data on lecanemab, a drug that could reshape the landscape of Alzheimer’s disease (AD) treatment. As the conference approaches, excitement is p... |
| Jul 22, 2024 | EISAI TO PRESENT DUAL-ACTING LECANEMAB THREE YEAR EFFICACY AND SAFETY DATA AND DISCUSS LONG-TERM OUTCOMES OF CONTINUED TREATMENT AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2024 | Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline will be shared, including the importance of continued treatment of AD, which is a progressive neurodegenerative disease that begins before plaque deposition and... |
| Jul 12, 2024 | Leqembi approved for the treatment of Alzheimer’s disease in Israel | Leqembi approved for the treatment of Alzheimer’s disease in Israel
Fri, Jul 12, 2024 01:30 CET Report this content
Stockholm, Sweden, July 12, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqem... |
| Jul 11, 2024 | Leqembi approved for the treatment of Alzheimer’s disease in Hong Kong | Leqembi approved for the treatment of Alzheimer’s disease in Hong Kong
Thu, Jul 11, 2024 01:30 CET Report this content
Stockholm, Sweden, July 11, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that th... |
| Jun 28, 2024 | Leqembi[®] (lecanemab) launched in China | Leqembi[®] (lecanemab) launched in China
Fri, Jun 28, 2024 01:30 CET Report this content
Stockholm, Sweden, June 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (brand name in Ch... |
| Jun 19, 2024 | Польза для здоровья или маркетинг: большой гид по ортопедическим товарам | Содержание:
Какими бывают ортопедические товары и кому они нужны
Какие товары нужны для профилактики
Что насчет ортопедической обуви и стелек
Валик для спины, специальный стул и топпер на диван: нужны ли дополнительные ортопедические товары... |
| May 24, 2024 | Leqembi[®] approved for the treatment of Alzheimer’s disease in South Korea | Leqembi[®] approved for the treatment of Alzheimer’s disease in South Korea
Fri, May 24, 2024 12:55 CET Report this content
Stockholm, Sweden, May 24, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the Ministry o... |
| May 23, 2024 | Health | Could current COVID vaccines protect against future outbreaks? New study offers hope | What is immune imprinting?
Researchers from Washington University’s School of Medicine in St. Louis evaluated the ability of the COVID-19 shots to build up memory in the immune system through a process called immune imprinting.
“Immune impr... |
| May 15, 2024 | Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for subcutaneous maintenance dosing | Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for subcutaneous maintenance dosing
Wed, May 15, 2024 01:30 CET Report this content
Stockholm, Sweden, May 15, 2024 – BioArctic AB's (publ) (... |
| May 13, 2024 | AMERICAN SKIN ASSOCIATION HONORS SPOTS PROGRAM WITH INAUGURAL 2024 RESEARCH ACHIEVEMENT AWARD IN COMMUNITY EDUCATION/OUTREACH | NEW YORK, May 13, 2024 /PRNewswire/ -- American Skin Association (ASA) is thrilled to announce that the SPOTS (Sun Protection Outreach Teaching by Students) program will receive the inaugural 2024 Research Achievement Award in Community Edu... |
| Apr 17, 2024 | Health | Ten doctors on FDA panel reviewing Abbott heart device had financial ties with company | David Hilzenrath, Holly K. Hacker | KFF Health News (TNS)
When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company ... |
| Apr 7, 2024 | Mental health chatbots powered by artificial intelligence developed as a therapy support tool | Artificial intelligence has found its way into nearly every part of our lives – forecasting weather, diagnosing diseases, writing term papers. and now, AI is probing that most human of places, our psyches -- offering mental health support, ... |
| Apr 1, 2024 | Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer’s disease to the U.S. FDA completed | Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer’s disease to the U.S. FDA completed
Mon, Apr 01, 2024 01:40 CET Report this content
Stockholm, Sweden, April 1, 2024 – BioArctic AB’... |
| Mar 22, 2024 | Lecanemab deliberations at the CHMP regarding the Marketing Authorisation Application in the EU have been rescheduled due to procedural reasons | Lecanemab deliberations at the CHMP regarding the Marketing Authorisation Application in the EU have been rescheduled due to procedural reasons
Fri, Mar 22, 2024 12:30 CET Report this content
Stockholm, Sweden March 22, 2024 – BioArctic AB:... |
| Mar 16, 2024 | The Foundation for Women's Cancer is Calling on Everyone Connected to Women's Health to Move Today for More Tomorrows | Move4Her: Powering Gyn Cancer Research, Education, and Awareness
Move4Her, the Foundation for Women's Cancer's signature annual fundraising campaign, kicks off its fifth year of fundraising to help power research, education and aw... |
| Mar 13, 2024 | Study shows improved hand function using Carbonhand | Study shows improved hand function using Carbonhand
Wed, Mar 13, 2024 22:40 CET Report this content
Today, a study on Improved physical function using a power-enhancing glove in persons with Inclusion Body Myositis was presented at the Glob... |
| Mar 11, 2024 | New data on lecanemab presented at the 2024 AD/PD™ congress | New data on lecanemab presented at the 2024 AD/PD™ congress
Mon, Mar 11, 2024 08:00 CET Report this content
Stockholm, March 11, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai presented new data on lecanemab (br... |
| Nov 7, 2023 | Nationwide Medicare Program Fails to Improve Mental Health, New Study Shows | Jace Dela Cruz, Tech Times 07 November 2023, 05:11 am
A new study suggests that a nationwide Medicare program designed to improve health care and reduce costs by providing financial incentives to doctors and hospitals has resulted in no imp... |
| Jul 18, 2023 | Washington University Doctors Achieve First-Ever Robotic Liver Transplantation | Inno Flores, Tech Times 18 July 2023, 10:07 pm
Doctors in the United States have achieved a major milestone by successfully conducting a robotic liver transplant procedure. This took place at Barnes-Jewish Hospital, signifying a remarkable ... |
| May 17, 2023 | Understanding the Latest Advances in Alzheimer’s Diagnostics | Alzheimer’s Diagnostics: Advancing the State of the Art
Understanding the Latest Advances in Alzheimer’s Diagnostics
This iSelect Deep Dive offers valuable insights into cutting-edge research on Alzheimer’s diagnostics. The discussion cover... |
| Nov 20, 2022 | Democracies Must Empower a Biotech Future for All | Editor’s Note: Although the science of biotechnology is moving forward at breakneck speed, regulation, diplomatic agreements, and other forms of control remain limited at best. Stanford University’s Megan Palmer, Georgetown’s Andrew Imbrie ... |
| Sep 27, 2022 | Still Suffering After Corona Virus: Next Steps for Long Haulers | Dr. Rashmi Gulati, MD, Board Certifed in Internal Medicine
People who have had COVID were 80% more likely to have seizures, 43% more likely to have mental health issues like anxiety, 35% more likely to have headaches.
Help Yourself - Yes, y... |
| Jul 25, 2022 | How Dangerous Is Covid-19 Now? | How dangerous is Covid-19 now? getty |
| Nov 17, 2021 | Human Stem Cells Experiment Cures Diabetes on Mice; Can It Be Used for People Soon? | Isaiah Richard, Tech Times 17 November 2021, 09:11 pm
Human Stem Cells are now being used in experiments, and it has successfully been found that it has cured Diabetes for mice, a promising potential cure that can be applied for humans soon... |
| Sep 1, 2021 | 7 benefits of kale, from improving digestion to helping fight cancer | Kale can help ensure that you get the nutrients that you need. Ron Levine/Getty Images
Kale is packed with minerals like iron, manganese, calcium, copper, and potassium.
It may also help fight heart disease by lowering cholesterol and aidin... |
| May 13, 2021 | The success of a novel scoliosis surgery hinges on when growth spurts hit. Can new tools better predict them? | Mia Schloegel was 11 when they found the curve in her spine.
She was at her yearly pediatrician’s visit when her uncle — also her doctor — had her lean over, in a standard childhood check for scoliosis. “He noticed I had kind of a hump on o... |
| May 10, 2021 | Women who drink 2 sodas a day have a higher risk of developing colorectal cancer before they reach 50, study finds | Drinking sugary beverages every day may increase your risk of early-onset colorectal cancer, research suggests.
A large study found that women who had two or more sugary drinks a day were more likely to develop colorectal cancer before age ... |
| May 4, 2020 | Exercising Bayh-Dole march-in rights would handicap Covid-19 innovation | Scientists across America are working hard to develop treatments for and vaccines against the novel coronavirus that causes Covid-19. Unfortunately, several activist groups are making their jobs harder.
Doctors Without Borders is urging gov... |
| Mar 22, 2020 | IBM, White House, Department of Energy, and others launch consortium to give coronavirus researchers access to supercomputers | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Following the launch of its 2020 Call for Code Gl... |
| Jan 22, 2019 | Simple blood test could help detect damage in the brain 16 years before Alzheimer's symptoms develop | Changes in the levels of a protein in the blood could help detect damage in the brain almost 16 years before the symptoms of Alzheimer's disease actually develop, according to a new study by scientists from the Washington University Sc... |
| Dec 10, 2018 | Летающие автомобили, «умная» пыль, нейроморфные устройства: какие технологии получат развитие к 2030 году Статьи редакции | Подборка эксперта в сфере искусственного интеллекта Эдриэна Бука.
2 2 комментария
4165 просмотров
Скучные и ожидаемые технологии
Искусственный интеллект, машинное обучение, глубокое обучение. ИИ часто переоценивают, но это важная технология... |
| Aug 11, 2017 | Here's why Sucampo paid $200M for its PhIII Niemann-Pick drug | Investigators have outlined the results of a small, single-arm study of a new drug for Niemann-Pick type C disease which inspired a $200 million biotech buyout earlier this year.
The drug is cyclodextrin, or at least a uniqu... |
| Jun 15, 2016 | Morning Read: AMA to take on NRA over gun violence, Facebook tackles suicide prevention | “Even as America faces a crisis unrivaled in any other developed country, the Congress prohibits the CDC from conducting the very research that would help us understand the problems associated with gun violence and determine how to reduce t... |
| Morning Read: AMA to take on NRA over gun violence, Facebook tackles suicide prevention | TOP STORIES
At its annual meeting on Tuesday, the AMA declared gun violence a public health crisis in the U.S. and is gearing up to lobby Congress to overturn a 20-year-old ban on the CDC researching the topic. That means the physician grou... |
| Long Covid is responsible for about a third of unfilled jobs in the U.S., new research suggests | America's ongoing labor shortage begs an important question: Where have all the workers gone?
There are 10.7 million unfilled jobs in the U.S., according to the latest data from the U.S. Bureau of Labor Statistics. Some economists poin... |
| An exercise pill may soon offer the same benefits as a workout, scientists say | You know exercise is good for your health, but life can get in the way of your physical fitness. Perhaps you don’t have as much time to hit the gym as you’d like, or have a medical condition that prevents you from exercising at all. Maybe y... |
| Long Covid may be ‘the next public health disaster’ — with a $3.7 trillion economic impact rivaling the Great Recession | Long Covid is a chronic illness resulting from a Covid-19 infection. It goes by many names, including long-haul Covid, post-Covid or post-acute Covid syndrome.
Not much is yet known about the illness. Its symptoms number in the hundreds and... |
| What to watch today: S&P 500 looks to add to Friday’s record high close | U.S stock futures were mixed Monday after the S&P 500 closed at another record high Friday and had its best weekly gain since February. The Nasdaq, which dipped Friday from a record close the previous session, logged its best week since... |
| Risk of a dangerous new Covid variant in China is ‘quite low,’ U.S. health expert says | It’s unlikely that a dangerous new Covid-19 variant is spreading in China, said Dr. Chris Murray, director of the Institute for Health Metrics and Evaluation.
There were likely billions of omicron infections worldwide this year, but no new ... |
